-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 10c, Beats on Revenue
-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c
-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 3c
-
-
-
-
-
-
-
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
TFF Pharmaceuticals Inc. (TFFP) Reports Q4, Provides Business Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

